Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kamchatskenergo reported for 3 months of 2024 by RAS

5/3/24 KCHE

KSC reported for 3 months of 2024 by RAS

5/3/24 KTSB

Board of Directors of Seligdar recommended that dividends be paid for 2023

5/3/24 SELG

Himprom reported for 2023 by IFRS

5/2/24 HIMCP

Himprom reported for the 3 months of 2024 by RAS

5/2/24 HIMCP

Board of Directors of Renaissance Insurance recommended that dividends be paid for 2023

5/2/24 RENI

Shareholders of Lipetsk Energy Supply Company approved dividends for 3 months 2024

5/2/24 LPSB

KLVZ Kristall first time reported by IFRS

5/2/24 KLVZ

KVLZ Kristall reported for 2023 by RAS

5/2/24 KLVZ

OMZ reported for 3 months of 2024 by RAS

5/2/24 OMZZP